What is the price target for DHR stock?
30 analysts have analysed DHR and the average price target is 263.58 USD. This implies a price increase of 35.35% is expected in the next year compared to the current price of 194.75.
NYSE:DHR • US2358511028
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DANAHER CORP (DHR).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-17 | Baird | Maintains | Outperform -> Outperform |
| 2026-04-14 | Barclays | Maintains | Overweight -> Overweight |
| 2026-04-13 | Goldman Sachs | Maintains | Buy -> Buy |
| 2026-04-06 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-01-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-29 | Jefferies | Maintains | Buy -> Buy |
| 2026-01-07 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-05 | Guggenheim | Maintains | Buy -> Buy |
| 2025-12-15 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-09 | Goldman Sachs | Initiate | Buy |
| 2025-12-02 | Morgan Stanley | Initiate | Overweight |
| 2025-10-23 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-22 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-22 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-08 | Rothschild & Co | Downgrade | Buy -> Neutral |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-22 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-23 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-07-23 | UBS | Maintains | Buy -> Buy |
| 2025-07-23 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-23 | Baird | Maintains | Outperform -> Outperform |
| 2025-07-18 | Baird | Maintains | Outperform -> Outperform |
| 2025-07-11 | ScotiaBank | Upgrade | Sector Perform -> Sector Outperform |
| 2025-07-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-06-24 | Barclays | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 23.89B -10.33% | 23.875B -0.06% | 24.568B 2.90% | 25.903B 5.43% | 27.389B 5.74% | 29.283B 6.92% | 31.621B 7.98% | 32.28B 2.08% | N/A | N/A | |
| EBITDA YoY % growth | 7.445B -23.70% | 7.561B 1.56% | 7.829B 3.54% | 8.279B 5.75% | 8.955B 8.17% | 9.637B 7.62% | 10.747B 11.52% | 11.614B 8.07% | N/A | N/A | |
| EBIT YoY % growth | 5.279B -29.95% | 5.209B -1.33% | 5.382B 3.32% | 7.335B 36.29% | 7.896B 7.65% | 8.518B 7.88% | 9.784B 14.86% | 10.629B 8.64% | 11.394B 7.20% | 11.964B 5.00% | |
| Operating Margin | 22.10% | 21.82% | 21.91% | 28.32% | 28.83% | 29.09% | 30.94% | 32.93% | N/A | N/A | |
| EPS YoY % growth | 8.52 -22.19% | 7.49 -12.09% | 7.80 4.14% | 8.49 8.87% | 9.21 8.41% | 10.17 10.48% | 11.34 11.52% | 12.45 9.80% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.96 4.08% | 1.90 5.46% | 2.09 10.69% | 2.54 13.88% | 2.12 8.24% | 2.10 10.41% | 2.25 7.33% | 2.73 7.62% | 2.29 8.25% | 2.16 3.13% | 2.45 9.31% | 3.05 11.60% |
| Revenue Q2Q % growth | 6.059B 5.54% | 6.219B 4.77% | 6.359B 5.06% | 7.261B 6.19% | 6.398B 5.59% | 6.592B 6.00% | 6.688B 5.17% | 7.615B 4.88% | 6.751B 5.52% | 6.997B 6.14% | 7.098B 6.13% | 8.101B 6.38% |
| EBITDA Q2Q % growth | 1.919B 2.07% | 1.883B -4.03% | 2.038B -31.56% | 2.447B -38.25% | 2.078B 8.29% | 2.061B 9.45% | 2.187B 7.31% | 2.606B 6.50% | 2.231B 7.36% | 2.136B 3.64% | 2.388B 9.19% | 2.904B 11.44% |
| EBIT Q2Q % growth | 1.678B 30.18% | 1.635B 115.13% | 1.773B 53.64% | 2.135B 40.83% | 1.804B 7.51% | 1.768B 8.13% | 1.909B 7.67% | 2.351B 10.12% | 1.999B 10.81% | 1.89B 6.90% | 2.139B 12.05% | 2.657B 13.02% |
All data in USD
30 analysts have analysed DHR and the average price target is 263.58 USD. This implies a price increase of 35.35% is expected in the next year compared to the current price of 194.75.
DANAHER CORP (DHR) will report earnings on 2026-04-21, before the market open.
The consensus EPS estimate for the next earnings of DANAHER CORP (DHR) is 1.96 USD and the consensus revenue estimate is 6.06B USD.
The expected long term growth rate for DANAHER CORP (DHR) is 5.72%.